These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 36606427)
1. Integrative analysis of the proteome and transcriptome in gastric cancer identified LRP1B as a potential biomarker. Miao J; Yang Z; Guo W; Liu L; Song P; Ding C; Guan W Biomark Med; 2022 Oct; 16(15):1101-1111. PubMed ID: 36606427 [No Abstract] [Full Text] [Related]
2. Correlation between Hu S; Zhao X; Qian F; Jin C; Hou K Comput Math Methods Med; 2021; 2021():1522250. PubMed ID: 34603481 [TBL] [Abstract][Full Text] [Related]
3. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer. Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221 [TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer. Lu YJ; Wu CS; Li HP; Liu HP; Lu CY; Leu YW; Wang CS; Chen LC; Lin KH; Chang YS Genes Chromosomes Cancer; 2010 May; 49(5):412-24. PubMed ID: 20095042 [TBL] [Abstract][Full Text] [Related]
5. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin. Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387 [TBL] [Abstract][Full Text] [Related]
6. Profiling of gastric cancer cell-surface markers to achieve tumour-normal discrimination. Toh J; Hoppe MM; Thakur T; Yang H; Tan KT; Pang B; Ho S; Roy R; Ho KY; Yeoh KG; Tan P; Sundar R; Jeyasekharan A BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816956 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer. Yasufuku I; Saigo C; Kito Y; Yoshida K; Takeuchi T J Mol Histol; 2021 Apr; 52(2):165-172. PubMed ID: 33389427 [TBL] [Abstract][Full Text] [Related]
8. Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis. Song Y; Wang J; Sun J; Chen X; Shi J; Wu Z; Yu D; Zhang F; Wang Z Genomics Proteomics Bioinformatics; 2020 Dec; 18(6):679-695. PubMed ID: 33607292 [TBL] [Abstract][Full Text] [Related]
9. Plasma membrane proteomic analysis of human Gastric Cancer tissues: revealing flotillin 1 as a marker for Gastric Cancer. Gao W; Xu J; Wang F; Zhang L; Peng R; Shu Y; Wu J; Tang Q; Zhu Y BMC Cancer; 2015 May; 15():367. PubMed ID: 25948494 [TBL] [Abstract][Full Text] [Related]
10. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer. Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374 [TBL] [Abstract][Full Text] [Related]
11. Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray. Yang L; Wang J; Li J; Zhang H; Guo S; Yan M; Zhu Z; Lan B; Ding Y; Xu M; Li W; Gu X; Qi C; Zhu H; Shao Z; Liu B; Tao SC Mol Cell Proteomics; 2016 Feb; 15(2):614-23. PubMed ID: 26598640 [TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer. Liang MK; Liang XQ; Zhong J; Wei YT; Lian ZP; Huang ZK; Liang J J Ethnopharmacol; 2021 Apr; 270():113787. PubMed ID: 33422657 [TBL] [Abstract][Full Text] [Related]
13. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144 [TBL] [Abstract][Full Text] [Related]
14. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer. Li F; Yoshizawa JM; Kim KM; Kanjanapangka J; Grogan TR; Wang X; Elashoff DE; Ishikawa S; Chia D; Liao W; Akin D; Yan X; Lee MS; Choi R; Kim SM; Kang SY; Bae JM; Sohn TS; Lee JH; Choi MG; Min BH; Lee JH; Kim JJ; Kim Y; Kim S; Wong DTW Clin Chem; 2018 Oct; 64(10):1513-1521. PubMed ID: 30097497 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer. Gao J; Cao R; Mu H Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487 [TBL] [Abstract][Full Text] [Related]
16. Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine. Sinnarasan VSP; Paul D; Das R; Venkatesan A OMICS; 2023 Jun; 27(6):260-272. PubMed ID: 37229622 [TBL] [Abstract][Full Text] [Related]
17. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer. Zhu C; Xiao D Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815 [TBL] [Abstract][Full Text] [Related]
18. Importin-4 functions as a driving force in human primary gastric cancer. Xu X; Zhang X; Xing H; Liu Z; Jia J; Jin C; Zhang Y J Cell Biochem; 2019 Aug; 120(8):12638-12646. PubMed ID: 30861176 [TBL] [Abstract][Full Text] [Related]
19. A systematic review of microRNA expression profiling studies in human gastric cancer. Shrestha S; Hsu SD; Huang WY; Huang HY; Chen W; Weng SL; Huang HD Cancer Med; 2014 Aug; 3(4):878-88. PubMed ID: 24902858 [TBL] [Abstract][Full Text] [Related]
20. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells. Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]